Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients

Heart Failure Clinical Trial

— MTM  

Official title:

Multi-Disciplinary Discharge Counseling and MTM Services After Discharge for Heart Failure Patients

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01822171
• Other study ID #: PSPH-002-Pharm
• Status: Terminated
• Phase: N/A
• First received: January 7, 2013
• Last updated: May 21, 2013
• Start date: January 2013
• Est. completion date: May 2013

Study information

• Verified date: May 2013
• Source: Providence Health & Services
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Readmission to a hospital shortly after discharge is a common and costly problem. In the United States patients with a diagnosis of heart failure currently experience an elevated 30 day readmission rate of approximately 20%. By providing patients with medication related counseling at discharge by a pharmacist, home medications at discharge, and seeing the patient again in a pharmacist-run Medication Therapy Management (MTM) clinic 7 days after discharge, the study anticipates achieving its primary goal of showing a reduction in the readmission rate. Secondary goals are: 1) to determine patients understanding of the medication they are taking, 2) to evaluate satisfaction with the comprehensive discharge counseling service, and 3) determine the number of interventions made and benefit of the MTM clinic.

Description:

The active arm of this study (medication related hospital discharge counseling by a pharmacist, home medications, and 7 day follow-up visit at a pharmacist run MTM clinic) is available to all subjects. To study the primary goal of reducing the 30 day readmission rate the data obtained from the active arm subjects will be compared to a match group of hospitalized patients that were previously discharged with a diagnosis of heart failure. The data for all secondary study goals will be obtained directly from the active arm subjects.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 1
• Est. completion date: May 2013
• Est. primary completion date: May 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Heart Failure with high risk for readmission.

• Enroll in study prior to hospital discharge.

Exclusion Criteria:

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Heart Failure

Intervention

Other:
• Discharge medication counseling from a pharmacist
Patient will be educated about proper dosing instructions, potential side effects, and when to recontact the treating physician office.
• Home medication if needed
Patient will be provided with medication to take home, when needed.
• Follow-up visit at Medication Therapy Management clinic
This comprehensive Medication Therapy Management clinic follow-up visit is scheduled for 7 days post hospital discharge. The approximately 1 hour visit is scheduled with a pharmacist to review current drug therapy and make recommendations, if needed, to improve medication utilization.

Locations

Country	Name	City	State
United States	Providence Centralia Hospital	Centralia	Washington
United States	Providence St. Peter Hospital	Olympia	Washington

Sponsors (1)

Lead Sponsor	Collaborator
Providence Health & Services

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reduction in hospital readmissions	The readmission rate for the 50 subjects involved in this study will be compared to an equal number patients retrospectively reviewed from a 2011 patient list and matched for heart failure severity. The primary outcome will based on a comparison of the ratio of patients readmitted to the hospital before the discharge instruction program started and after.	30 day	No
Secondary	Patient assessment of home medications knowledge at time of hospital discharge	Post hospital discharge the subject are asked to rate their knowledge regarding the medication they are taking at home on a scale of 1 to 10. The data obtained in this study will be compared to the same data and patient matched population obtained in 2011.	3 days	No
Secondary	Patient satisfaction with comprehensive discharge counseling service.	The satisfaction survey consists of five interview questions, where the subject subjectively scores each question on a scale of 1 to 10, developed specifically for this study.	7 Days	No
Secondary	Number of interventions made at the MTM clinic.	The number of drug related therapy interventions the pharmacist makes during the 7 day follow-up visit will be counted. Interventions may include: identifying: an inappropriate drug, inappropriate dose, duplication of medications, or a missing medication to optimize drug therapy.	7 Days.	No
Secondary	Types of interventions made at the MTM clinic.	The types of intervention the pharmacist may work on during the 7 day follow-up visit include inappropriate drug, inappropriate dose, duplication of medications, missing medication to optimize drug therapy. Other types of interventions may be revealed during this study.	7 days	No